Literature DB >> 26226540

Caffeine Toxicity Due to Supplement Use in Caffeine--Naïve Individual: A Cautionary Tale.

Robert M Lystrup1, Jeffery C Leggit2.   

Abstract

Thousands of military members self-medicate with dietary supplements containing unknown quantities of pharmacologically active compounds. These poorly regulated substances can cause real harm to the military population, especially when they contain stimulants such as caffeine. When taken regularly, caffeine has several performance-enhancing benefits. However, when used excessively or in vulnerable populations, caffeine can cause several unwanted side effects such as nervousness, sensory disturbances, insomnia, arrhythmia, excitability, inattentiveness, restlessness, mood changes, gastrointestinal disturbances, and even psychosis. Vulnerable patients include the caffeine-naïve, physiologically stressed, young, and mentally ill patients. One such case describes a caffeine-naïve service member who suffered an adverse reaction after taking an allegedly moderate dose of caffeine from a pill he obtained from a teammate. This case highlights the importance of supplement awareness among service members, increased provider vigilance, third party verification, and enhanced regulation on the approval and marketing of dietary supplements. Reprint &
Copyright © 2015 Association of Military Surgeons of the U.S.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26226540     DOI: 10.7205/MILMED-D-15-00045

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  2 in total

1.  Health Related Nutritional Knowledge and Dietary Behavior Regarding Caffeine Intake among High School Students in Yongin Region.

Authors:  Seong Yeong Kim
Journal:  Osong Public Health Res Perspect       Date:  2018-12

2.  Safety Pharmacological Evaluation of the Coffee Component, Caffeoylquinic Acid, and Its Metabolites, Using Ex Vivo and In Vitro Profiling Assays.

Authors:  Yuto Amano; Hiroshi Honda; Yuko Nukada; Naohiro Ikeda; Masayuki Yamane; Koji Nakano; Akiyo Kameyama; Osamu Morita
Journal:  Pharmaceuticals (Basel)       Date:  2019-07-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.